LFCR FY 2022 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$111M+10.3% YoY

Gross Profit

$39M35.1% margin

Operating Income

-$12M-10.6% margin

Net Income

-$117M-104.9% margin

EPS (Diluted)

$-3.97

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$53M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$275M

Total Liabilities

$187M

Stockholders' Equity

$88M

Cash & Equivalents

$991,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$111M	$101M	+10.3%
Gross Profit	$39M	$39M	+0.3%
Operating Income	-$12M	-$9M	-33.6%
Net Income	-$117M	-$32M	-261.4%